Polycystic ovary syndrome: A review for dermatologists Part I. Diagnosis and manifestations

被引:35
作者
Housman, Elizabeth [1 ]
Reynolds, Rachel V. [2 ]
机构
[1] Harvard Univ, Sch Med, Dept Internal Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Dermatol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
acanthosis nigricans; acne; anovulation; hirsutism; hyperandrogenism; insulin resistance; polycystic ovary syndrome; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; SYNDROME PCOS; RISK-FACTORS; WOMEN; PREVALENCE; HORMONE; HYPERANDROGENISM;
D O I
10.1016/j.jaad.2014.05.007
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women who are of reproductive age. The pathogenesis involves several associated hormonal pathways that culminate in metabolic, reproductive, and cardiovascular effects. The hallmark features of hyperandrogenism and hyperinsulinemia have systemic long-term implications. Dermatologists frequently evaluate and manage the cutaneous manifestations of PCOS (ie, acanthosis nigricans, hirsutism, acne, and alopecia), and therefore play a key role in its diagnosis and management. In part I of this continuing medical education article, we review the definition, etiology, pathogenesis, and clinical features of PCOS.
引用
收藏
页码:847 / 858
页数:12
相关论文
共 70 条
  • [1] PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM
    ADAMS, J
    POLSON, DW
    FRANKS, S
    [J]. BRITISH MEDICAL JOURNAL, 1986, 293 (6543) : 355 - 359
  • [2] Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome
    Adams, JM
    Taylor, AE
    Crowley, WF
    Hall, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) : 4343 - 4350
  • [3] American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee, 2005, Endocr Pract, V11, P126
  • [4] RESPONSES OF SERUM GONADOTROPINS TO LH-RELEASING HORMONE AND ESTROGENS IN JAPANESE WOMEN WITH POLYCYSTIC OVARIES
    AONO, T
    MIYAZAKI, M
    MIYAKE, A
    KINUGASA, T
    KURACHI, K
    MATSUMOTO, K
    [J]. ACTA ENDOCRINOLOGICA, 1977, 85 (04): : 840 - 849
  • [5] Hirsutism and acne in polycystic ovary syndrome
    Archer, JS
    Chang, RJ
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) : 737 - 754
  • [6] A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain
    Asunción, M
    Calvo, RM
    San Millán, JL
    Sancho, J
    Avila, S
    Escobar-Morreale, HF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) : 2434 - 2438
  • [7] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2745 - 2749
  • [8] Azziz R, 2000, J PEDIATR ENDOCR MET, V13, P1303
  • [9] Ultrasound assessment of the polycystic ovary: international consensus definitions
    Balen, AH
    Laven, JSE
    Tan, SL
    Dewailly, D
    [J]. HUMAN REPRODUCTION UPDATE, 2003, 9 (06) : 505 - 514
  • [10] HYPERSECRETION OF LUTEINIZING-HORMONE AND THE POLYCYSTIC-OVARY-SYNDROME
    BALEN, AH
    [J]. HUMAN REPRODUCTION, 1993, 8 : 123 - 128